A batch of medicines will be adjusted and suspended due to high prices!

Recently, the Pharmaceutical Price and Bidding and Procurement Office of Hunan Provincial Medical Insurance Bureau issued the "Notice on Price Correction and Price Restriction of Some Drugs on the Internet".
10 drugs such as famotidine, which were reported to be inflated by real names, were subject to price correction and price limit listings
.
According to the notice, the list of common names of drugs listed on the Internet for price correction and price limit includes 9 injections and one sustained-release preparation, including citicoline, betahistine, piracetam, ligustrazine, famo Tidine, ranitidine, troxerutin, aminophylline, dihyprophylline, theophylline
.
Among them, ranitidine, troxerutin, betahistine, etc.
are all commonly used varieties
.
The analysis believes that carrying out drug price correction and price limit hanging on the Internet is an effective means to solve the falsely high drug prices and rectify the order of the pharmaceutical market
.
With the efforts of relevant departments in Hunan Province, there may be a large number of price reductions for common drugs with inflated prices in the future, benefiting more patients
.
Coincidentally, before Hunan Province, in fact, the Sichuan Provincial Pharmaceutical Equipment Recruitment and Procurement Center has just withdrawn the 186 products that concealed the lowest listing price/bidding price (Tibet price) in the country
.
The drugs withdrawn include lidocaine hydrochloride injection, ornidazole tablets, ribavirin tablets and other commonly used clinical western medicines, as well as Chinese patent medicines such as Niuhuangjiedu tablets and Banlangen granules
.
In this regard, the industry believes that more and more regions are monitoring drug prices and adjusting prices, which also means that a new round of price adjustments and withdrawals from the Internet will be launched nationwide
.
It is understood that with the continuous advancement of the centralized drug procurement organized by the state, the reshuffle of the pharmaceutical market has accelerated, and the competition among pharmaceutical companies has become more and more fierce; in fact, in recent years, drug price adjustment and withdrawal from the Internet have long been the norm
.
For example, in September last year, the Hainan Provincial Medical Insurance Bureau, in conjunction with the Provincial Government Service Center, took the lead in creating a new model of medical recruitment and price supervision in the country, and issued the "Interim Measures for the Management of Pharmaceutical Recruitment and Price Monitoring and Management in Hainan Province".
Drugs have chosen active price adjustment on the Hainan Provincial Pharmaceutical Centralized Purchasing Platform
.
Among them, a batch of results showed that all 689 drugs were reduced in price, with an average drop of 30.
91%, and the highest drop was 96.
8%.
The unit price of individual anti-cancer drugs dropped by more than 10,000 yuan
.
It is worth mentioning that the new drug list has been officially implemented, and news of another large number of drug price cuts in Hubei, Hebei, Yunnan, Liaoning, Chongqing, Beijing and other places has also been put on the agenda
.
In addition to the new version of medical insurance that continues to promote drug price reductions, the analysis believes that according to the "14th Five-Year Plan for National Medical Security" issued by the State Council, a comprehensive mechanism for monitoring the procurement price of drugs and medical consumables in public medical institutions and sharing transaction price information will be established.
Mechanism to improve the ability to analyze, early warning and respond to abnormal changes in the prices of drugs and medical consumables It will be more abundant, and the strategy of "removing the network" and "limiting price" will continue to be implemented in the industry
.